Lmr Partners LLP Arcellx, Inc. Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$27.49 - $46.9 $57,509 - $98,114	-2,092 Reduced 20.49%	8,116 $256,000
Q1 2023 May 15, 2023	BUY	$26.92 - $33.94 $274,799 - $346,459	10,208 New	10,208 $314,000
Q2 2022 Aug 15, 2022	SELL	$7.21 - $24.43 $23,504 - $79,641	-3,260 Reduced 18.73%	14,143 $256,000
Q1 2022 May 16, 2022	BUY	$12.97 - $19.14 $225,716 - $333,093	17,403 New	17,403 $244,000

204

44.1M

2.23M

907K

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $2.99B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.